Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Leonard

Showing results (101-110 of 686) with videos related to

Pageof 69
Sort By:
Archives of Oral Biology|July 1, 1970
Histochemical observations on the phosphatase activity of the developing dental primordia in the Swiss albino mouse as detected by azo dye and osmium-capture methodsE P Leonard, D V Provenza
Nucleosides, Nucleotides & Nucleic Acids|September 21, 2001
Synthesis and base pairing properties of 9-deazapurine N7-nucleosides in oligonucleotide duplexes and triplexesP Leonard, T Wiglenda, F Seela
Leukemia & Lymphoma|May 30, 2001
Interleukin-12 gene therapy vaccines: directing the immune system against minimal residual leukemiaK Dunussi-Joannopoulos, J P Leonard
Neuropharmacology|January 1, 1996
Effect of protein kinase-C activation on the Mg(2+)-sensitivity of cloned NMDA receptorsD A Wagner, J P Leonard
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 4, 2017
Urothelial carcinoma of the bladder in a pediatric patientElke E Mau, Michael P Leonard
Seminars in Oncology|February 1, 2017
Immunotherapy of non-Hodgkin's lymphoma with hLL2 (epratuzumab, an anti-CD22 monoclonal antibody) and Hu1D10 (apolizumab)John P Leonard, Brian K Link
Histochemie. Histochemistry. Histochimie|March 26, 1973
Alkaline phosphatase activity in sequential mouse molar tooth development. An electron microscopic studyE P Leonard, D V Provenza
Neuron|January 1, 1990
Apparent desensitization of NMDA responses in Xenopus oocytes involves calcium-dependent chloride currentJ P Leonard, S R Kelso
Leukemia & Lymphoma|February 28, 2007
Therapy for older patients with diffuse large cell lymphoma: targeting the treatment to the patientAbby B Siegel, John P Leonard
Oncogene|May 29, 2007
Preclinical and clinical evaluation of epratuzumab (anti-CD22 IgG) in B-cell malignanciesJ P Leonard, D M Goldenberg
Pageof 69

Showing results (101-110 of 686) with videos related to

Sort By:
Pageof 69
Archives of Oral Biology|July 1, 1970
Histochemical observations on the phosphatase activity of the developing dental primordia in the Swiss albino mouse as detected by azo dye and osmium-capture methodsE P Leonard, D V Provenza
Nucleosides, Nucleotides & Nucleic Acids|September 21, 2001
Synthesis and base pairing properties of 9-deazapurine N7-nucleosides in oligonucleotide duplexes and triplexesP Leonard, T Wiglenda, F Seela
Leukemia & Lymphoma|May 30, 2001
Interleukin-12 gene therapy vaccines: directing the immune system against minimal residual leukemiaK Dunussi-Joannopoulos, J P Leonard
Neuropharmacology|January 1, 1996
Effect of protein kinase-C activation on the Mg(2+)-sensitivity of cloned NMDA receptorsD A Wagner, J P Leonard
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 4, 2017
Urothelial carcinoma of the bladder in a pediatric patientElke E Mau, Michael P Leonard
Seminars in Oncology|February 1, 2017
Immunotherapy of non-Hodgkin's lymphoma with hLL2 (epratuzumab, an anti-CD22 monoclonal antibody) and Hu1D10 (apolizumab)John P Leonard, Brian K Link
Histochemie. Histochemistry. Histochimie|March 26, 1973
Alkaline phosphatase activity in sequential mouse molar tooth development. An electron microscopic studyE P Leonard, D V Provenza
Neuron|January 1, 1990
Apparent desensitization of NMDA responses in Xenopus oocytes involves calcium-dependent chloride currentJ P Leonard, S R Kelso
Leukemia & Lymphoma|February 28, 2007
Therapy for older patients with diffuse large cell lymphoma: targeting the treatment to the patientAbby B Siegel, John P Leonard
Oncogene|May 29, 2007
Preclinical and clinical evaluation of epratuzumab (anti-CD22 IgG) in B-cell malignanciesJ P Leonard, D M Goldenberg
Pageof 69